Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. World Antibiotic Awareness Week: tackling multi-drug resistant bacteria
  2. Beigene receives its first FDA approval for a MCL drug
  3. One step closer to a Chlamydia vaccine
  4. Takeda’s Ninlaro meets primary endpoint in multiple myeloma
  5. Artios in-licenses MD Anderson-Shangpharma’s ART inhibitor programme

Latest Content

World Antibiotic Awareness Week: tackling multi-drug resistant bacteria

World Antibiotics Awareness Week focuses on the threat of antibiotic resistance to key part. A key part of solving the AMR crisis is to develop novel therapies to tackle resistance, particularly targeting those bacteria that are resistant to multiple antibiotics. One innovative approach is leveraging biology to create phage-based therapies.

Brochure

Our goal is to develop and maintain the most effective sterilisation processes for your products, bringing them to market in the fastest, most efficient and safest way possible.

Beigene receives its first FDA approval for a MCL drug

Chinese-headquartered Beigene has announced the US Food and Drug Administration (FDA) has approved Brukinsa (zanubrutinib) to treat patients with relapsed or refractory mantle cell lymphoma (MCL), making this the first Beigene-discovered product to gain FDA approval.

One step closer to a Chlamydia vaccine

Researchers from Danish SSI and Imperial College London have published promising results from the first clinical trials of a vaccine against chlamydia. This represents a significant step toward a preventative treatment for the world’s most common sexually transmitted bacterial disease. Allie Nawrat examines the history of chlamydia treatment and the next steps in the development of the vaccine.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Close
Close
Close

Go Top